Literature DB >> 3550288

Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.

M Samoszuk, S Sholly, A L Epstein.   

Abstract

An IgG2a murine monoclonal antibody derived against human eosinophils was shown to immunoprecipitate the 78,000 dalton form of human eosinophil peroxidase (EPO). To confirm the specificity of the antibody, we used a glucose-oxidase avidin biotin procedure to immunostain 32 human cell lines and tissues. An eosinophilic subline of HL-60 promyelocytic leukemia was the only cell type other than eosinophils to be recognized by the antibody. Because previous reports have described occult eosinophilic degranulation in tissues with a variety of pathological conditions, we immunostained cryostat sections of four consecutive lymph node biopsies of nodular sclerosis Hodgkin's disease with the monoclonal antibody. Our objective was to characterize by immunohistology the eosinophilic infiltration in a lymphoma that frequently contains substantial numbers of eosinophils. In all four cases of nodular sclerosis Hodgkin's disease, there was striking and extensive deposition of EPO in a dendritic pattern throughout the connective tissue and collagen bands. The extent of deposition of EPO in the bands far exceeded the degree of infiltration by intact eosinophils, as determined by examination of routinely stained tissue sections. A similar dendritic pattern was not observed in any of six benign lymph nodes that were immunostained for EPO. We conclude that the monoclonal antibody described in this report is specific for EPO and that eosinophils extensively degranulate and release EPO in the bands of nodular sclerosis Hodgkin's disease. Moreover, the degree of eosinophilic infiltration in this disorder cannot be assessed solely on the basis of intact eosinophils.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3550288

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Phase I imaging study of Hodgkin's disease and non-Hodgkin's lymphomas with radiolabeled antibody to eosinophil peroxidase.

Authors:  M Samoszuk; A L Anderson; F Wang; P Braunstein; H Majmundar; J Ravel; E Ramzi; L Slater
Journal:  Cell Biophys       Date:  1992 Aug-Dec

2.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

3.  Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.

Authors:  M K Samoszuk; V Nguyen; I Gluzman; J H Pham
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Degranulating eosinophils in human endometriosis.

Authors:  R D Blumenthal; M Samoszuk; A P Taylor; G Brown; R Alisauskas; D M Goldenberg
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

5.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

Authors:  H Noguchi; G M Kephart; T V Colby; G J Gleich
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.

Authors:  M Kadin; J Butmarc; A Elovic; D Wong
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.